Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Cancer cells must develop distinct metabolic adaptations to survive in challenging metastatic environments. Here, the authors find, via an in vivo RNAi screen, that the aldo-keto reductase AKR1B10 limits the toxic side effects of oxidative stress to sustain fatty acid oxidation and promote metastati...
Guardado en:
Autores principales: | Antoinette van Weverwijk, Nikolaos Koundouros, Marjan Iravani, Matthew Ashenden, Qiong Gao, George Poulogiannis, Ute Jungwirth, Clare M. Isacke |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58bc19073e294af1870da5b4ec93e431 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
por: Ute Jungwirth, et al.
Publicado: (2021) -
Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
por: Tiangen Wu, et al.
Publicado: (2021) -
Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death
por: Nang Lae Lae Phoo, et al.
Publicado: (2021) -
The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
por: Jixuan Liu, et al.
Publicado: (2021) -
A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.
por: Ivo J Huijbers, et al.
Publicado: (2010)